| 前收市價 | 205.00 |
| 開市 | 204.60 |
| 買盤 | 204.00 x 0 |
| 賣出價 | 205.60 x 0 |
| 今日波幅 | 204.60 - 204.60 |
| 52 週波幅 | 148.80 - 213.70 |
| 成交量 | |
| 平均成交量 | 0 |
| 市值 | 無 |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | 無 |
| 業績公佈日 | 2024年4月30日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
ZacksRevvity's (RVTY) New Launch to Boost Tuberculosis Testing
Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.
ZacksCONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
ZacksVeeva's (VEEV) AI Partner Program to Develop GenAI Solutions
Veeva (VEEV) announces the Veeva AI Partner Program, which is expected to provide partners assistance to combine Generative AI solutions with Veeva Vault applications.
